Abbott Laboratories (Pakistan) Ltd ABOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 328.92
- Price/Sales
- 0.95
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,430
- Website
- https://www.pk.abbott
Comparables
Valuation
|
Metric
|
ABOT
|
PAKT
|
TRG
|
|---|---|---|---|
Price/Earnings (Normalized) | 328.92 | 8.49 | — |
Price/Book Value | 2.90 | 5.30 | 0.70 |
Price/Sales | 0.95 | 2.48 | — |
Price/Cash Flow | 33.56 | 8.71 | — |
Price/Earnings
ABOT
PAKT
TRG
Financial Strength
|
Metric
|
ABOT
|
PAKT
|
TRG
|
|---|---|---|---|
Quick Ratio | 0.56 | 0.71 | 0.08 |
Current Ratio | 1.38 | 1.61 | 0.09 |
Interest Coverage | 84.45 | 70.31 | — |
Quick Ratio
ABOT
PAKT
TRG
Profitability
|
Metric
|
ABOT
|
PAKT
|
TRG
|
|---|---|---|---|
Return on Assets (Normalized) | 0.44% | 32.29% | −28.35% |
Return on Equity (Normalized) | 0.94% | 76.32% | −33.82% |
Return on Invested Capital (Normalized) | −2.02% | 58.47% | −33.82% |
Return on Assets
ABOT
PAKT
TRG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Tzjvklrn | Jxgjhm | $70.5 Bil | |
ZTS
| Zoetis Inc Class A | Rvlvkdbdzw | Shj | $70.0 Bil | |
HLN
| Haleon PLC ADR | Tgsscyrxx | Ypng | $36.3 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zmvnfjmx | Hsr | $14.3 Bil | |
VTRS
| Viatris Inc | Lxvkctwb | Nlwd | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zbvwtlslq | Gkrc | $12.0 Bil | |
CTLT
| Catalent Inc | Nwqwktxbh | Yfqgpb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nvmbxdw | Zwdc | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Njtqhylk | Ggbg | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wtpfdzycr | Zbbfhbc | $3.4 Bil |